Propranolol (Inderal) Extended-Release Recall: What Migraine Patients Should Check
One lot of propranolol (Inderal) extended-release 60 mg capsules was recalled on November 16, 2026 over possible metal pieces. Here is how to check your bottle and get a replacement quickly.
On this pageJump to a section8
What Happened
On November 16, 2026, Breckenridge Pharmaceutical announced a voluntary, nationwide, consumer-level recall of one lot of generic propranolol (Inderal) hydrochloride extended-release capsules, 60 mg. The company said capsules from this lot could contain pieces of metal. The recall was done with the knowledge of the US Food and Drug Administration.
Propranolol is one of the oldest and most widely used migraine preventives, and the extended-release form carries an FDA indication for migraine prevention. It remains a recommended option in the AAN and AHS migraine prevention guideline, so a fair number of people reading this blog take it every day.
The recall is narrow. It covers a single lot of one strength from one company, shipped to wholesalers and pharmacies between October 26 and November 4, 2026. Many people on propranolol take a different form, strength or lot, and checking takes a couple of minutes.
The Recalled Product
These are the identifying details from the company announcement. The lot number is the detail that matters most, since the same NDC number is used for other, unaffected lots.
| Detail | Recalled product |
|---|---|
| Drug | Propranolol (Inderal) hydrochloride extended-release capsules, USP |
| Strength | 60 mg |
| Bottle size | 100 capsules |
| NDC | 51991-817-01 |
| Lot number | PK25110035 |
| Expiration date | May 2029 |
| Distributor | Breckenridge Pharmaceutical, Inc. |
| Manufacturer | Adare Pharma Solutions |
| Shipped to pharmacies | October 26 to November 4, 2026, nationwide |
Not included: propranolol (Inderal) immediate-release tablets, extended-release capsules in other strengths, other lots of the 60 mg capsule, and propranolol made by other companies.
Why It Was Recalled
According to the announcement, metal contamination was found in a separate lot that never reached the market. The recalled lot shared an intermediate material with that lot, and that material is suspected as the source of the metal. The recall is a precaution based on that shared material.
The company said that swallowing a capsule with metal in it could cut soft tissue in the mouth, esophagus, stomach or intestine. As of the announcement, it was not aware of any adverse events judged to be related to the recall.
A consumer-level recall reaches past wholesalers and pharmacies to the people who already have the product at home. That is why you are asked to check the bottle you already have.
How to Check Your Bottle
- Confirm you take the extended-release capsule (often written as ER, XL or LA on the label) at the 60 mg strength. If you take tablets or a different strength, this recall does not apply to you.
- Look for the lot number. It is usually printed on the original manufacturer bottle, not always on the pharmacy sticker.
- If your pharmacy poured the capsules into its own vial, the lot number may not be on what you have at home. Call the pharmacy and ask whether your fill came from lot PK25110035.
- Some companies repackage this product under their own label and NDC, so a bottle that does not say Breckenridge could still contain capsules from this lot. The pharmacist can trace it.
A refill picked up before late October 2026 is unlikely to be from this lot, given the shipping dates. Refills from the first half of November are the ones to check first.
If You Have the Recalled Lot
The company advises people to stop taking capsules from the recalled lot right away, contact their clinician for advice and a replacement, and return unused capsules to the pharmacy where they got them.
The practical goal is to swap the capsules while keeping treatment going. The propranolol label warns that suddenly stopping the drug has been linked to worsening chest pain and, in some cases, heart attack in people with coronary artery disease, and it recommends tapering over at least a few weeks when the drug is stopped on purpose. For that reason, call the pharmacy the same day rather than going without. Pharmacists can often refill from an unaffected lot or another manufacturer, and if a new prescription is needed, your physician can send one.
If you take propranolol for migraine and also have heart disease, high blood pressure or a fast heart rhythm, tell the pharmacist and physician that when you call, so they can prioritize getting you a replacement.
If you have already taken capsules from this lot and notice mouth or throat pain, pain or trouble swallowing, stomach pain, vomiting blood, or black or bloody stools, contact a physician promptly or seek urgent care.
What This Means for Your Migraine Plan
This recall concerns one batch. Nothing in the announcement changes how propranolol works as a migraine preventive, and there is no reason to abandon a preventive that is helping you. The label gives an initial migraine dose of 80 mg once daily with a usual effective range of 160 to 240 mg once daily, so people on extended-release propranolol may be taking other strengths that are not affected.
If you were already unsure whether propranolol is doing enough, the replacement call is a natural time to bring it up. The preventive response calculator can help you put numbers on it, and a short appointment summary sheet makes the conversation faster. For a broader look at the alternatives, see our overview of which migraine preventive medications work best and the research on candesartan (Atacand) for migraine prevention, another blood pressure drug used for migraine.
If you take propranolol alongside another preventive, our guide to preventives that are more often combined safely covers how those pairings are usually handled.
Contacts and Reporting
- Recall questions: Qualanex, 1-855-736-0807 or recall@qualanex.com, Monday to Friday, 9 a.m. to 5 p.m. Eastern Time.
- Side effects or quality problems: FDA MedWatch at www.fda.gov/medwatch, or call 1-800-332-1088 for a reporting form.
- Medical advice and replacement: your pharmacist and the physician who prescribes your propranolol.
- One lot (PK25110035) of propranolol extended-release 60 mg capsules, 100-count bottles, was recalled on November 16, 2026.
- The concern is possible metal pieces, and no related harms had been reported at the time of the announcement.
- Tablets, other strengths, other lots and other manufacturers are not part of this recall.
- If you have the lot, stop using those capsules and call your pharmacy the same day for a replacement so treatment is not interrupted.
- Repackaged or pharmacy-poured capsules may not show the lot number, so ask the pharmacist to check.
This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment. Apart from setting aside capsules from the recalled lot, do not stop or change a prescribed medication without talking with your physician or pharmacist. If you think you have been harmed by a medication, seek medical care.
References
- Breckenridge Pharmaceutical, Inc. Breckenridge Pharmaceutical, Inc. Issues Voluntary Nationwide Consumer-Level Recall of One Lot of Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg, Due to Potential Metal Contamination. Company announcement. November 16, 2026.
- Propranolol hydrochloride capsule, extended release. Prescribing information (AvKARE repackaged label, source NDC 51991-817). DailyMed. US National Library of Medicine.


This article is for education and is not medical advice. Talk with your own clinician before starting, stopping or changing any treatment.


